Article
Identifying Advanced Esophageal Squamous Cell Carcinoma Patients Who Benefit from Immunotherapy Maintenance Following Immunotherapy and Radiotherapy: A Multicenter Study
2026-02-02
Abstract excerpt
<title>Abstract</title> <p>Objective Patients with advanced esophageal squamous cell carcinoma (ESCC) who have received first-line immunotherapy and radiotherapy remain uncertain as to which individuals may benefit from immunotherapy maintenance. This study aims to establish a deep learning model based on interactive automated 3D segmentation to predict immunotherapy + radiotherapy efficacy and identify patients...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8db8458d-7895-5379-ac7e-d749a6264ff0
- DOI
- 10.21203/rs.3.rs-8639357/v1
